S&P 500   5,249.78 (+0.02%)
DOW   39,754.40 (-0.01%)
QQQ   445.50 (+0.15%)
AAPL   171.32 (-1.15%)
MSFT   421.14 (-0.07%)
META   490.57 (-0.67%)
GOOGL   150.71 (-0.11%)
AMZN   181.19 (+0.76%)
TSLA   176.61 (-1.79%)
NVDA   910.28 (+0.86%)
NIO   4.71 (+0.86%)
AMD   181.70 (+1.17%)
BABA   72.32 (+1.02%)
T   17.52 (-0.17%)
F   13.22 (+1.23%)
MU   117.62 (-1.28%)
CGC   9.02 (-5.55%)
GE   177.12 (-1.67%)
DIS   123.09 (+1.74%)
AMC   3.82 (-11.98%)
PFE   27.85 (+0.25%)
PYPL   66.66 (+0.14%)
XOM   115.30 (+0.29%)
S&P 500   5,249.78 (+0.02%)
DOW   39,754.40 (-0.01%)
QQQ   445.50 (+0.15%)
AAPL   171.32 (-1.15%)
MSFT   421.14 (-0.07%)
META   490.57 (-0.67%)
GOOGL   150.71 (-0.11%)
AMZN   181.19 (+0.76%)
TSLA   176.61 (-1.79%)
NVDA   910.28 (+0.86%)
NIO   4.71 (+0.86%)
AMD   181.70 (+1.17%)
BABA   72.32 (+1.02%)
T   17.52 (-0.17%)
F   13.22 (+1.23%)
MU   117.62 (-1.28%)
CGC   9.02 (-5.55%)
GE   177.12 (-1.67%)
DIS   123.09 (+1.74%)
AMC   3.82 (-11.98%)
PFE   27.85 (+0.25%)
PYPL   66.66 (+0.14%)
XOM   115.30 (+0.29%)
S&P 500   5,249.78 (+0.02%)
DOW   39,754.40 (-0.01%)
QQQ   445.50 (+0.15%)
AAPL   171.32 (-1.15%)
MSFT   421.14 (-0.07%)
META   490.57 (-0.67%)
GOOGL   150.71 (-0.11%)
AMZN   181.19 (+0.76%)
TSLA   176.61 (-1.79%)
NVDA   910.28 (+0.86%)
NIO   4.71 (+0.86%)
AMD   181.70 (+1.17%)
BABA   72.32 (+1.02%)
T   17.52 (-0.17%)
F   13.22 (+1.23%)
MU   117.62 (-1.28%)
CGC   9.02 (-5.55%)
GE   177.12 (-1.67%)
DIS   123.09 (+1.74%)
AMC   3.82 (-11.98%)
PFE   27.85 (+0.25%)
PYPL   66.66 (+0.14%)
XOM   115.30 (+0.29%)
S&P 500   5,249.78 (+0.02%)
DOW   39,754.40 (-0.01%)
QQQ   445.50 (+0.15%)
AAPL   171.32 (-1.15%)
MSFT   421.14 (-0.07%)
META   490.57 (-0.67%)
GOOGL   150.71 (-0.11%)
AMZN   181.19 (+0.76%)
TSLA   176.61 (-1.79%)
NVDA   910.28 (+0.86%)
NIO   4.71 (+0.86%)
AMD   181.70 (+1.17%)
BABA   72.32 (+1.02%)
T   17.52 (-0.17%)
F   13.22 (+1.23%)
MU   117.62 (-1.28%)
CGC   9.02 (-5.55%)
GE   177.12 (-1.67%)
DIS   123.09 (+1.74%)
AMC   3.82 (-11.98%)
PFE   27.85 (+0.25%)
PYPL   66.66 (+0.14%)
XOM   115.30 (+0.29%)
NASDAQ:ALHC

Alignment Healthcare (ALHC) Stock Price, News & Analysis

$4.74
-0.05 (-1.04%)
(As of 10:09 AM ET)
Today's Range
$4.73
$4.82
50-Day Range
$4.63
$7.46
52-Week Range
$4.48
$9.20
Volume
56,257 shs
Average Volume
896,027 shs
Market Capitalization
$895.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.61

Alignment Healthcare MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
100.7% Upside
$9.61 Price Target
Short Interest
Bearish
5.32% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.48mentions of Alignment Healthcare in the last 14 days
Based on 12 Articles This Week
Insider Trading
Acquiring Shares
$496,460 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.59) to ($0.49) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.22 out of 5 stars

Medical Sector

348th out of 939 stocks

Hospital & Medical Service Plans Industry

7th out of 11 stocks

ALHC stock logo

About Alignment Healthcare Stock (NASDAQ:ALHC)

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

ALHC Stock Price History

ALHC Stock News Headlines

Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
ALHC Apr 2024 7.500 call
ALHC Apr 2024 7.500 put
See More Headlines
Receive ALHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alignment Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/27/2024
Today
3/28/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Hospital & medical service plans
Sub-Industry
N/A
Current Symbol
NASDAQ:ALHC
Fax
N/A
Employees
1,536
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$9.61
High Stock Price Target
$12.00
Low Stock Price Target
$4.50
Potential Upside/Downside
+100.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
10 Analysts

Profitability

Net Income
$-148,020,000.00
Pretax Margin
-8.13%

Debt

Sales & Book Value

Annual Sales
$1.82 billion
Book Value
$0.84 per share

Miscellaneous

Free Float
177,072,000
Market Cap
$905.21 million
Optionable
Optionable
Beta
1.34
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

ALHC Stock Analysis - Frequently Asked Questions

Should I buy or sell Alignment Healthcare stock right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Alignment Healthcare in the last twelve months. There are currently 1 sell rating, 4 hold ratings, 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ALHC shares.
View ALHC analyst ratings
or view top-rated stocks.

What is Alignment Healthcare's stock price target for 2024?

10 analysts have issued 12-month target prices for Alignment Healthcare's shares. Their ALHC share price targets range from $4.50 to $12.00. On average, they expect the company's share price to reach $9.61 in the next twelve months. This suggests a possible upside of 100.7% from the stock's current price.
View analysts price targets for ALHC
or view top-rated stocks among Wall Street analysts.

How have ALHC shares performed in 2024?

Alignment Healthcare's stock was trading at $8.61 at the beginning of the year. Since then, ALHC stock has decreased by 44.4% and is now trading at $4.79.
View the best growth stocks for 2024 here
.

Are investors shorting Alignment Healthcare?

Alignment Healthcare saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 4,780,000 shares, an increase of 7.9% from the February 29th total of 4,430,000 shares. Based on an average daily trading volume, of 866,600 shares, the short-interest ratio is currently 5.5 days. Approximately 5.3% of the shares of the company are short sold.
View Alignment Healthcare's Short Interest
.

When is Alignment Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our ALHC earnings forecast
.

How were Alignment Healthcare's earnings last quarter?

Alignment Healthcare, Inc. (NASDAQ:ALHC) issued its quarterly earnings data on Tuesday, February, 27th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.22) by $0.03. The company earned $465.39 million during the quarter, compared to the consensus estimate of $444.56 million. Alignment Healthcare had a negative net margin of 8.12% and a negative trailing twelve-month return on equity of 75.64%. The company's revenue was up 28.6% on a year-over-year basis. During the same period last year, the company earned ($0.31) EPS.

What guidance has Alignment Healthcare issued on next quarter's earnings?

Alignment Healthcare issued an update on its first quarter 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $590.0 million-$600.0 million, compared to the consensus revenue estimate of $550.8 million.

When did Alignment Healthcare IPO?

Alignment Healthcare (ALHC) raised $490 million in an initial public offering (IPO) on Friday, March 26th 2021. The company issued 27,200,000 shares at a price of $17.00-$19.00 per share. Goldman Sachs, Morgan Stanley, J.P. Morgan, BofA Securities and William Blair served as the underwriters for the IPO and UBS Investment Bank, Piper Sandler and Raymond James were co-managers.

Who are Alignment Healthcare's major shareholders?

Alignment Healthcare's stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (4.84%), Vanguard Group Inc. (4.84%), Wellington Management Group LLP (2.03%), Brown Advisory Inc. (1.98%), Price T Rowe Associates Inc. MD (0.57%) and Price T Rowe Associates Inc. MD (0.57%). Insiders that own company stock include Atlantic (Aln Hlth) L General, Christopher J Joyce, Dawn Christine Maroney, Dinesh M Kumar, Donald Steven Furman, Jeffrey H Margolis, John E Kao, Joseph S Konowiecki, Michael Curtis Foster, Richard A Cross, Robert L Scavo, Robert Thomas Freeman, Warburg Pincus Llc and Warburg Pincus Partners Gp Llc.
View institutional ownership trends
.

How do I buy shares of Alignment Healthcare?

Shares of ALHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ALHC) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners